Stockscreener 앱 받기
27.76
0.15%
-0.04
Oculis Holding Ag 주식(OCS)의 최신 뉴스
Oculis (NASDAQ:OCS) Releases Quarterly Earnings Results, Misses Expectations By $0.08 EPS - MarketBeat
H.C. Wainwright raises Oculis stock price target to $44 on trial progress - Investing.com
Oculis Holding AG Announces Participation in Upcoming Investor Conferences and Highlights Late-Stage Pipeline Developments - Quiver Quantitative
Oculis Publishes 2025 Consolidated Financial Statements - GlobeNewswire
Why Oculis (OCS) Is Down 6.2% After New Equity Programs To Fund Late-Stage Trials - simplywall.st
Oculis Holding AG renews $100 million at-the-market offering program - Investing.com Australia
Stifel raises Oculis stock price target to $50 on pipeline progress - Investing.com
Oculis Holding AG renews $100 million at-the-market offering program By Investing.com - Investing.com South Africa
Oculis Files 2025 Financials and Renews $100 Million ATM Program - TipRanks
Oculis Holding (NASDAQ: OCS) widens loss but ends 2025 with strong cash and $100m ATM capacity - Stock Titan
Oculis price target raised to $44 from $42 at H.C. Wainwright - TipRanks
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities - GlobeNewswire
Oculis (NASDAQ: OCS) 2025 20-F details losses, cash and trials - Stock Titan
HC Wainwright Issues Positive Forecast for Oculis (NASDAQ:OCS) Stock Price - MarketBeat
Oculis (NASDAQ:OCS) Stock Price Expected to Rise, Needham & Company LLC Analyst Says - MarketBeat
Chardan Raises Price Target on Oculis Holding to $53 From $51, Keeps Buy Rating - marketscreener.com
Oculis Holding's Q4 Net Loss Narrows; Plans Phase 3 Trial Readouts For OCS-01 In Q2,2026 - Nasdaq
Oculis Reports Q4 and Full-Year 2025 Results, Shares Update - InvisionMag.com
Oculis Posts 2025 Results, Extends Cash Runway and Advances Late-Stage Ophthalmology Pipeline - TipRanks
Oculis Holding AG (OCS) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
Oculis reports Q4 EPS (CHF 0.42c) vs. (CHF 0.67) last year - TipRanks
[6-K] Oculis Holding AG Current Report (Foreign Issuer) | OCS SEC FilingForm 6-K - Stock Titan
Eye drug firm Oculis eyes 3 major 2026 vision milestones after $119M loss - Stock Titan
Oculis (OCS) to Release Quarterly Earnings on Tuesday - MarketBeat
Oculis Holding AG (NASDAQ:OCS) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Earnings To Watch: Oculis Holding AG (OCS) Reports Q4 2025 Resul - GuruFocus
OCS Earnings History & Surprises | EPS & Revenue Results | OCULIS HOLDING AG (NASDAQ:OCS) - ChartMill
Discipline and Rules-Based Execution in OCS Response - Stock Traders Daily
Oculis Holding AG expected to post a loss of 42 rappen a shareEarnings Preview - TradingView
Oculis Holding AG (OCS) Stock Analysis: A Promising 52.55% Upside Potential in the Biotech Sector - DirectorsTalk Interviews
Oculis (NASDAQ:OCS) Sets New 12-Month HighHere's What Happened - MarketBeat
Bull Bear: Can Oculis Holding AG continue delivering strong returnsJuly 2025 Macro Moves & Community Trade Idea Sharing Platform - baoquankhu1.vn
Big Picture: Will Oculis Holding AG benefit from green energy policiesTrade Risk Report & Fast Entry Momentum Alerts - baoquankhu1.vn
Will Oculis Holding AG benefit from green energy policiesMarket Activity Recap & Fast Gain Stock Tips - mfd.ru
Oculis Holding AG (OCS) Investor Outlook: Analyst Ratings Signal a 59.98% Upside Potential - DirectorsTalk Interviews
Fund Flows: Whats the profit margin of Oculis Holding AG Equity Warrant2025 Top Decliners & Low Risk High Win Rate Picks - baoquankhu1.vn
Oculis (NASDAQ:OCS) Hits New 1-Year HighHere's Why - MarketBeat
Aug EndMonth: Can Oculis Holding AG beat the S P 5002025 Major Catalysts & Daily Risk Controlled Trade Plans - baoquankhu1.vn
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated - Yahoo Finance UK
Behavioral Patterns of OCS and Institutional Flows - Stock Traders Daily
Oculis Appoints Katie Kazem as Chief Legal Officer - InvisionMag.com
Oculis Appoints Katie Kazem as Chief Legal Officer to Strengthen Leadership Team - Quiver Quantitative
Why Oculis Holding AG stock remains undervaluedJuly 2025 Closing Moves & Growth Focused Stock Reports - mfd.ru
Earnings Miss: Should you avoid Oculis Holding AG Equity Warrant stock right now - baoquankhu1.vn
Can Oculis Holding AG Equity Warrant stock surprise with earnings upsideJuly 2025 Setups & Stock Portfolio Risk Management - mfd.ru
How does Oculis Holding AG compare to its peersVolume Spike & Capital Efficiency Focused Ideas - mfd.ru
Published on: 2026-02-15 01:23:26 - mfd.ru
Oculis Holding AG (OCS) Stock Analysis: A 61% Potential Upside In The Biotech Arena - DirectorsTalk Interviews
What’s the outlook for Oculis Holding AG’s sector2025 Technical Overview & Precise Swing Trade Alerts - mfd.ru
OCS Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Market Wrap: Whats next for Oculis Holding AG stock2025 Institutional Moves & Precise Swing Trade Alerts - baoquankhu1.vn
Why Oculis Holding AG stock is favored by top institutionsPortfolio Profit Report & Daily Growth Stock Tips - mfd.ru
Will Oculis Holding AG benefit from rate cutsJuly 2025 Movers & Verified Momentum Stock Ideas - mfd.ru
Is Oculis Holding AG Equity Warrant attractive for institutional investorsTrade Signal Summary & Weekly Stock Performance Updates - mfd.ru
Aug Selloffs: Can Oculis Holding AG maintain sales growth2025 Technical Patterns & Safe Capital Growth Stock Tips - baoquankhu1.vn
Head to Head Review: Rezolute (NASDAQ:RZLT) versus Oculis (NASDAQ:OCS) - Defense World
(OCS) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Oculis Holding AG (OCS) Stock Analysis: A Biotech Player With A 65% Upside Potential - DirectorsTalk Interviews
Oculis Holding AG (NASDAQ:OCS) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
4.16%
0.71%
자본화:
|
볼륨(24시간):